BackSpero Therapeutics Overview

Spero Therapeutics Operating Income

Operating Income for SPRO.

Quarterly Operating Income

$-7538000.00
↓ 48.83% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$7.17M
↓ 109.16% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin